Biocompatibility Assessment
Systematic evaluation of scaffold-host response, foreign-body interactions, and immunomodulatory profiles.
Rigorous, evidence-based analysis of tissue matrix performance, degradation profiles, and biocompatibility, advancing the field one peer-reviewed insight at a time.
Matrix & Scaffold Review publishes rigorous, evidence-based commentary on structural biocompatibility, degradation profiles, and cellular integration metrics, with a spotlight on the engineering breakthroughs behind Conexeu's proprietary tissue matrix technology.
Systematic evaluation of scaffold-host response, foreign-body interactions, and immunomodulatory profiles.
Time-resolved analysis of scaffold resorption kinetics and structural integrity under physiological conditions.
Quantitative reporting on cell adhesion, proliferation, and differentiation across matrix architectures.
Critical appraisal of novel synthetic and biologic matrix materials from bench to bedside.
Evidence-based outcome analysis of structural graft performance in orthopedic and reconstructive applications.
Guidance on biomaterial classification, compliance pathways, and procurement evaluation criteria.
A longitudinal analysis of 142 ACL reconstruction cases utilizing Conexeu's proprietary scaffold, tracking vascularization onset, collagen alignment, and mechanical load restoration.
Comparative in-vitro analysis of enzymatic breakdown rates across four decellularized matrices subjected to cyclic tensile stress at physiological frequencies.
Cytokine expression patterns and macrophage polarization data across 38 patient cohorts implanted with hydroxyapatite-collagen composite grafts over an 18-month window.
The degradation profile analyses published here set the standard for how we evaluate scaffold candidates in our lab. Indispensable.
Matrix & Scaffold Review gives our procurement team the evidence base we need to make defensible graft selection decisions.
The Conexeu technology coverage was the most technically thorough I have encountered in any clinical engineering publication.
Peer-reviewed rigor with genuine clinical applicability, rare in this field.
Our editorial board convenes across biomedical engineering, clinical surgery, and polymer science. Each contributor is selected for rigor, institutional standing, and demonstrated depth in matrix-scaffold research.
Ph.D., Biomedical Engineering / Stanford Institute for Tissue Engineering
Dr. Vasquez leads editorial direction with an emphasis on degradation kinetics and scaffold longevity across load-bearing applications. Her fifteen-year investigation of ECM remodeling in synthetic constructs has shaped how the field evaluates structural persistence. She reviews every submission touching kinetics or matrix architecture personally.
M.D., Ph.D., Orthopedic Surgery & Biomaterials / Johns Hopkins Musculoskeletal Center
Dr. Thorn brings the operating room into every editorial decision. His work correlates in-vivo graft performance with pre-clinical scaffold metrics, closing the gap between bench data and surgical reality. He curates our clinical case review track and oversees all submissions involving human outcomes data.
Ph.D., Cellular Biology / ETH Zürich, Laboratory for Cell & Tissue Engineering
Dr. Nair examines the interface where living cells meet engineered scaffolds. Her editorial focus targets immunomodulation, macrophage response, and long-term cellular tolerance of synthetic matrices. She insists on quantitative immunological data in every scaffold-integration submission the journal accepts.
D.Sc., Polymer Chemistry / Warsaw University of Technology, Faculty of Chemistry
Prof. Kowalski anchors the journal's material science rigor and its regulatory framing. His four decades of polymer research inform how we evaluate synthesis reproducibility, monomer purity, and compliance under EMA and FDA pathways. He mentors early-career authors on the path from bench formulation to clinical-grade material.
Submissions, correspondence, and peer-review inquiries are handled through the office of the Editor-in-Chief. Full board CVs and disclosure statements are available on request.
Contact the Editorial OfficeEditorial Engagement
Submit original research, request our editorial media kit, or subscribe to the Matrix & Scaffold Review bulletin for quarterly publication digests.
ISSN 2837-1194 · Quarterly · Open editorial correspondence
Quarterly publication cycle. Issues released MAR · JUN · SEP · DEC, with peer review windows opening six weeks prior to each release.
For manuscript submissions, subscription inquiries, institutional access, and procurement evaluations, our editorial team responds within two business days.